COVID-19 booster vaccination/booster vaccination
In the practice of DR. FRÜHWEIN & PARTNER in Munich
COVID-19 vaccines provide effective and sustained protection against severe illness and death from SARS-COV-2, although they cannot be used to safely rule out infection. Nevertheless, the risk of infection with COVID-19 is reduced and thus the risk of transmission to contacts is also minimized. Unvaccinated persons are thus particularly at risk.
As with most vaccinations, vaccine protection wears off over time, especially in terms of preventing infections without symptoms or with mild courses of disease. In elderly or immunocompromised patients, vaccinations are less effective due to the limited immune response, which is why vaccine breakthroughs can more frequently lead to more severe courses of disease.
THE STIKO CURRENTLY RECOMMENDS BOOSTER VACCINATIONS
with an mRNA vaccine for the following groups of people:
<h2>1. booster vaccination</h2>
<h3>with 3 months interval to the second vaccination/disease</h3>
Touch with the mouse pointer for more information.All adults and children/adolescents 12 years and older with an mRNA vaccine. Up to 30 years exclusively Comirnaty (Biontech/Pfizer)
<h2>2. booster vaccination</h2>
<h3>with 3 resp.6 Months interval to first booster vaccination/illness</h3>
Touch with the mouse pointer for more information.3 months interval for
- People from 70 years
- Residents and persons cared for in nursing facilities
- People with immunodeficiency from 5 years of age
6 months interval for
- Workers in medical facilities and nursing homes
- with an mRNA vaccine.
<h2>1. booster vaccination with 4 weeks interval</h2>
<h3>with 4 weeks interval to the second vaccination/disease</h3>
Touch with the mouse pointer for more information.- Immunocompromised patients
- Pre-vaccination with Johnson&Johnson vector vaccine to complete basic immunization.
- with an mRNA vaccine.